These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4962524)

  • 101. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.
    Phetsuksiri B; Jackson M; Scherman H; McNeil M; Besra GS; Baulard AR; Slayden RA; DeBarber AE; Barry CE; Baird MS; Crick DC; Brennan PJ
    J Biol Chem; 2003 Dec; 278(52):53123-30. PubMed ID: 14559907
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 103. ["2ND LINE" DRUG THERAPY IN CHRONIC TUBERCULOSIS DUE TO GERM RESISTANCE. (NEW METHODS OF DRUG ADMINISTRATION; NEW DRUGS)].
    HAMMERLI A; KRAMER EE; GALLINDO IS
    Hospital (Rio J); 1964 Feb; 65():365-88. PubMed ID: 14136756
    [No Abstract]   [Full Text] [Related]  

  • 104. [Isoxyl in the treatment of chronic lung tuberculosis].
    Tousek J; Jancíková M; Novák M; Feitová S; Jancík E
    Prax Pneumol; 1965 Dec; 19(12):751-65. PubMed ID: 5894931
    [No Abstract]   [Full Text] [Related]  

  • 105. [The sensitivity of mycobacteria to 4-4'-diisoamyloxythiocarbanalide (Isoxyl) and its determination in Löwenstein-Jensen medium].
    Meissner G; Stottmeier D
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 May; 130(4):289-95. PubMed ID: 5893629
    [No Abstract]   [Full Text] [Related]  

  • 106. [Clinical experiences with INH-isoxyl therapy of primary tuberculosis].
    Schmid PC
    Prax Pneumol; 1967 Oct; 21(10):617-26. PubMed ID: 5629058
    [No Abstract]   [Full Text] [Related]  

  • 107. [Incidence, clinical picture and treatment of reactivation of the process in patients suffering from pulmonary tuberculosis after surgical interventions].
    Rebrov AI; Fisher EF
    Grudn Khir; 1972; 14(2):95-7. PubMed ID: 4623981
    [No Abstract]   [Full Text] [Related]  

  • 108. Results of monotherapy with Isoxyl in untreated pulmonary tuberculosis cases of different difficulties and Isoxyl in routine-therapy.
    Kampelmann F
    Antibiot Chemother; 1970; 16():96-104. PubMed ID: 5535617
    [No Abstract]   [Full Text] [Related]  

  • 109. DETERMINATION OF THE SENSITIVITY OF MYCOBACTERIA TO ISOXYL IN VITRO.
    VIRTANEN S
    Ann Med Exp Biol Fenn; 1963; 41():430-5. PubMed ID: 14085830
    [No Abstract]   [Full Text] [Related]  

  • 110. [Clinical experiences with 2 new antitubercular agents: ethioniamide (iridoncin) and diisoamylhydroxythiocarbanilide (isoxyl)].
    RAUCH HW
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1963; 127():340-7. PubMed ID: 13973299
    [No Abstract]   [Full Text] [Related]  

  • 111. [On isoxyl treatment].
    Heidelbach H; Kampelmann ; Meissner G; Ohm W; Rauch HW; Schmelzer KH; Schmidt PG
    Prax Pneumol; 1966 Jul; 20(7):410-28. PubMed ID: 5951053
    [No Abstract]   [Full Text] [Related]  

  • 112. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 113. [Experimental trials and clinical observations on the use of intravenous morphazinamide in chronic pulmonary tuberculosis].
    Di Perna A; Berti R; Cinotti D
    Minerva Med; 1965 Sep; 56(71):2872-8. PubMed ID: 4954934
    [No Abstract]   [Full Text] [Related]  

  • 114. [Critical remarks on a clinical test of an antitubercular agent. Experiences with thiocarlide during collective work].
    Mlczoch F; Wildner F
    Prax Pneumol; 1969 Jan; 23(1):1-16. PubMed ID: 4978559
    [No Abstract]   [Full Text] [Related]  

  • 115. Susceptibility of mycobacteria to 4,4'-diisoamyloxythiocarbanilide.
    Verbist L
    Antimicrob Agents Chemother (Bethesda); 1965; 5():298-305. PubMed ID: 4160676
    [No Abstract]   [Full Text] [Related]  

  • 116. [Long-term treatment of pulmonary tuberculosis; experiences with combination therapy using isoxyl].
    Sighart H
    Prax Pneumol; 1966 Jan; 20(1):20-7. PubMed ID: 5330611
    [No Abstract]   [Full Text] [Related]  

  • 117. [Clinical studies on the tuberculostatic activity of isoxyl].
    Eule H; Ewert EG
    Prax Pneumol; 1966 Feb; 20(2):84-92. PubMed ID: 5951016
    [No Abstract]   [Full Text] [Related]  

  • 118. Clinical experience with thiocarlide (Isoxyl).
    Urbancik B
    Antibiot Chemother; 1970; 16():117-23. PubMed ID: 5535608
    [No Abstract]   [Full Text] [Related]  

  • 119. [Newest tuberculostatics; importance and feasibility of evaluation in a test tube].
    Trnka L; Havel A; Urbancik R
    Chemotherapy; 1966; 11(2):121-34. PubMed ID: 4959376
    [No Abstract]   [Full Text] [Related]  

  • 120. [Conditions for ethionamide activity and the formation of resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1979 Oct; (10):58-60. PubMed ID: 41236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.